We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$3.07B
Turnover
11.76%
1-Year Est. Return
40.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.77%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$914M
AUM Growth
+$67.7M
(+8%)
Cap. Flow
+$17.1M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
31.66%
Holding
292
New
16
Increased
25
Reduced
16
Closed
12
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$6.32M |
| 2 |
JPMorgan Chase
JPM
|
+$3.57M |
| 3 |
Pfizer
PFE
|
+$3.16M |
| 4 |
GSK
GSK
|
+$2.84M |
| 5 |
Nordson
NDSN
|
+$528K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLC
Clarcor
CLC
|
+$1.39M |
| 2 |
CLNY
Colony Capital, Inc.
CLNY
|
+$454K |
| 3 |
STJ
St Jude Medical
STJ
|
+$393K |
| 4 |
Idexx Laboratories
IDXX
|
+$389K |
| 5 |
Portland General Electric
POR
|
+$334K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.03% |
| 2 | Technology | 16.72% |
| 3 | Healthcare | 13.67% |
| 4 | Communication Services | 12.36% |
| 5 | Financials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Coca-Cola
KO
$396B
| $13M | 1.42% |
305,400
| – | – |
2016 Q1
4 quarters
|
|
27
Cisco
CSCO
$433B
| $12.8M | 1.4% |
378,097
| – | – |
2016 Q1
4 quarters
|
|
28
Microsoft
MSFT
$4.01T
| $12.6M | 1.38% |
192,059
| – | – |
2016 Q1
4 quarters
|
|
29
Verizon
VZ
$184B
| $12.5M | 1.37% |
256,300
| – | – |
2016 Q1
4 quarters
|
|
|
30
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $12.5M | 1.36% |
313,775
+163,775
| +109% | +$6.32M |
2016 Q4
1 quarter
|
|
|
ESRX
31
DELISTED
Express Scripts Holding Company
ESRX
| $12.2M | 1.33% |
184,863
| – | – |
2016 Q1
4 quarters
|
|
32
Aflac
AFL
$59.2B
| $11.5M | 1.26% |
317,000
| – | – |
2016 Q1
4 quarters
|
|
33
Eli Lilly
LLY
$1.12T
| $11M | 1.2% |
130,350
| – | – |
2016 Q1
4 quarters
|
|
34
Mondelez International
MDLZ
$80.4B
| $10.8M | 1.18% |
249,700
| – | – |
2016 Q1
4 quarters
|
|
35
Chevron
CVX
$430B
| $10.5M | 1.14% |
97,397
| – | – |
2016 Q1
4 quarters
|
|
36
SLB Ltd
SLB
$71.8B
| $10.2M | 1.12% |
130,637
| – | – |
2016 Q1
4 quarters
|
|
37
Amazon
AMZN
$2.75T
| $10M | 1.09% |
225,700
| – | – |
2016 Q1
4 quarters
|
|
38
The Kraft Heinz Company
KHC
$27.6B
| $9.45M | 1.03% |
104,066
| – | – |
2016 Q1
4 quarters
|
|
39
Thermo Fisher Scientific
TMO
$258B
| $9.22M | 1.01% |
60,000
| – | – |
2016 Q1
4 quarters
|
|
40
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $8.64M | 0.94% |
269,120
-6,856
| -2% | -$234K |
2016 Q1
4 quarters
|
|
41
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $7.28M | 0.8% |
30,900
| – | – |
2016 Q1
4 quarters
|
|
|
42
GSK
GSK
$98.2B
| $6.96M | 0.76% |
132,000
+56,000
| +74% | +$2.84M |
2016 Q4
1 quarter
|
|
43
WisdomTree Japan Hedged Equity Fund
DXJ
$2.35B
| $6.58M | 0.72% |
390,000
| – | – |
2016 Q1
4 quarters
|
|
44
Walmart Inc
WMT
$935B
| $6.55M | 0.72% |
272,475
+11,775
| +5% | +$271K |
2016 Q1
4 quarters
|
|
45
Intel
INTC
$504B
| $6.22M | 0.68% |
172,500
| – | – |
2016 Q1
4 quarters
|
|
46
iShares MSCI EAFE ETF
EFA
$76.9B
| $5.82M | 0.64% |
93,500
+4,500
| +5% | +$272K |
2016 Q1
4 quarters
|
|
47
Vanguard FTSE All-World ex-US ETF
VEU
$67.4B
| $5.45M | 0.6% |
114,000
| – | – |
2016 Q4
1 quarter
|
|
48
General Motors
GM
$73.4B
| $5.13M | 0.56% |
145,024
| – | – |
2016 Q4
1 quarter
|
|
49
Occidental Petroleum
OXY
$60.6B
| $4.95M | 0.54% |
78,200
| – | – |
2016 Q1
4 quarters
|
|
50
DELISTED
Hess
HES
| $4.77M | 0.52% |
99,000
| – | – |
2016 Q1
4 quarters
|
|
Similar funds
Henshaw Capital's Q1 2017 Portfolio in Review
As of Q1 2017, Henshaw Capital held 292 positions worth $914M, up 8% from $847M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Henshaw Capital's Q1 2017 filing shows 16 new, 25 increased, 16 reduced and 12 closed positions. Its largest new stake was Nordson: 4,459 shares worth $548K. The largest sale was Clarcor, an estimated $1.39M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Henshaw Capital's largest Q1 2017 buy was Nordson: 4,459 shares worth $548K.
- Henshaw Capital added most to Vanguard FTSE Emerging Markets ETF in Q1 2017, an estimated $6.32M increase.
- Henshaw Capital's biggest Q1 2017 reduction was Idexx Laboratories, cutting an estimated $389K.
- Henshaw Capital fully exited Clarcor in Q1 2017, selling an estimated $1.39M.
- Henshaw Capital's ten largest holdings make up 32% of its $914M portfolio in Q1 2017.
- Henshaw Capital opened 16 new positions and closed 12 in Q1 2017.
- Henshaw Capital's portfolio value rose 8% quarter-over-quarter to $914M.
Based on Henshaw Capital's 13F filing for Q1 2017, filed 28 May 2026.